)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
IRadimed
IRadimed (IRMD) investor relations material
IRadimed Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary1 May, 2026
Executive summary
Achieved 16th consecutive quarter of record revenues, with Q2 2025 revenue of $20.4 million, up 14% year-over-year, and Q1 2026 revenue of $22.0 million, up 13% year-over-year, driven by higher device sales and maintenance agreements.
Net income rose to $5.8 million ($0.45 per diluted share) in both Q2 2025 and Q1 2026, with GAAP diluted EPS up 18% and 22% year-over-year, respectively.
Gross profit margin remained strong, improving to 78% in Q2 2025 and 77% in Q1 2026.
FDA clearance and commercial launch of the MRidium 3870 IV pump system expected to drive significant future growth, with strong early customer interest and larger initial orders.
No material adverse impacts from ongoing geopolitical events or recent Supreme Court tariff rulings, though potential tariff refunds are being evaluated.
Financial highlights
Q2 2025 revenue: $20.4 million (+14% YoY); Q1 2026 revenue: $22.0 million (+13% YoY); MRI-compatible IV infusion pump systems revenue: $8.2 million (+19% YoY in Q2 2025), $7.7 million in Q1 2026.
Patient monitoring systems revenue: $5.9 million (+9% YoY in Q2 2025), $7.1 million in Q1 2026; disposables revenue up 14% to $4.2 million in Q2 2025.
Gross profit: $16 million (+14% YoY in Q2 2025); operating income: $6.8 million (+21% YoY in Q2 2025), $7.2 million (+33% YoY in Q1 2026); net income: $5.8 million (+18% YoY in Q2 2025, +24% YoY in Q1 2026).
Cash and equivalents: $53 million at Q2 2025, $56.4 million at Q1 2026; cash flow from operations: $7.7 million in Q2 2025, $8.3 million in Q1 2026.
Free cash flow: $4.9 million in Q2 2025, $7.8 million in Q1 2026; quarterly dividend of $0.17 per share for Q3 2025 and $0.20 per share for Q2 2026.
Outlook and guidance
Q3 2025 revenue expected at $20.5–$20.9 million (+12–14% YoY); Q2 2026 revenue expected between $20.0 million and $21.0 million.
Full-year 2025 revenue guidance raised to $80–$82.5 million (+9–13% YoY); 2026 guidance reaffirmed: revenue of $91.0–$96.0 million, GAAP diluted EPS of $1.90–$2.05, non-GAAP diluted EPS of $2.06–$2.21.
Anticipates operational inefficiencies in Q3 2025 due to facility transition, but expects continued strong growth and higher operating expenses in 2026.
Targeting $100 million revenue run rate in 2026, driven by new pump adoption and replacement cycle.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from IRadimed
- Director elections, auditor ratification, and executive pay are up for vote at the annual meeting.IRMD
Proxy filing30 Apr 2026 - Record Q4 and full-year revenue, strong margins, and 2026 growth outlook with new product launches.IRMDQ4 202510 Feb 2026
- Record Q2 revenue, margin, and net income growth support a strong outlook and ongoing dividends.IRMDQ2 20242 Feb 2026
- Record Q3 revenue, raised guidance, and strong cash flow highlight robust performance.IRMDQ3 202417 Jan 2026
- New MRI-safe IV pump launch and facility expansion set stage for rapid multi-year growth.IRMD43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026
- Q1 2025 delivered record revenue and earnings, with strong U.S. sales and robust margins.IRMDQ1 202527 Dec 2025
- Record revenue, higher dividend, and strong 2025 outlook driven by MRI device demand.IRMDQ4 202423 Dec 2025
- Shareholders will vote on director elections, auditor ratification, and executive pay, ensuring strong governance.IRMDProxy Filing1 Dec 2025
- Record Q2 revenue, FDA clearance, and new facility drive raised guidance and expansion.IRMDQ2 202516 Nov 2025
Next IRadimed earnings date
Q2 202631 Jul, 2026
IRadimed
Next IRadimed earnings date
Q2 202631 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage